Medical Market Directory
Search Medical Market
Contact
Sponsored Links
Main Menu
Home
Medical News - end 2009
Medical News
Aid and Disasters
Events and Conferences
Pharmacy
Organizations
MedicalResources
acai berry side effects
Colon Cleanse
fitness model
Tantric Massage London
Onlineclinic
Irritable-Bowel Syndrome
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
1
Furiex Receives FDA Fast Track Designation Of MuDelta For The Treatment Of Diarrhea-Predominant Irritable Bowel Syndrome
2
Symptoms In Irritable Bowel Syndrome Improved By Exercise
3
Salix Receives Anticipated FDA Complete Response Letter On XIFAXAN(R) 550 Mg Tablets Non-C IBS Supplemental New Drug Application
4
Peppermint Earns Respect In Mainstream Medicine
5
C. Difficile Increases Risk Of Death Sixfold In Patients With Inflammatory Bowel Disease
6
Ironwood And Forest To Present Linaclotide Results From Phase 3 Trials In Patients With Irritable Bowel Syndrome With Constipation
7
Scientists Unmask Mysterious Cells As Key 'Border Patrol Agents' In The Intestine
8
2011 Digestive Disease Week: UNC Research Highlights
9
Cedars-Sinai Research Deepens Understanding Of Most Common Gastrointestinal Disorder In U.S., Linking It To Bacterial Overgrowth, Food Poisoning
10
Study Suggests Digestive Problems Early In Life May Increase Risk For Depression
11
That Anxiety May Be In Your Gut, Not In Your Head
12
FDA Grants Fast Track Designation To Tioga Pharmaceuticals' Asimadoline For The Treatment Of Diarrhea-Predominant Irritable Bowel Syndrome
13
Scientists Target Possible Cause Of One Form Of Bowel Disease
14
N30 Pharma Announces FDA Approval To Initiate Phase 1 Clinical Trial For First-in-Class Drug
15
UCD Scientists Pinpoint Potential Key Regulator In Battle To Target Inflammatory Bowel Disease (IBD)
16
Proof That Irritable Bowel Syndrome Is Not In Your Head
17
Stress Management, Diet Changes Improve Irritable Bowel Syndrome Symptoms
18
Low Bone Mineral Density Common In Children And Teenagers With Inflammatory Bowel Disease
19
N30 Pharma Initiates Phase 1 Trials Of Novel Reductase Inhibitor
20
Ironwood And Forest Announce Positive Linaclotide Results From Phase 3 Trial In Patients With Irritable Bowel Syndrome With Constipation
<<
Start
<
Prev
1
2
3
4
5
Next
>
End
>>
Page 1 of 5